AngioDynamics Inc (ANGO) community

ANGONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends May 31

Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 12/308% below fair value

$11.87−0.12 (-0.96%)

Close on Nov 13, 2026Market cap $499.19MP/E –Yield –

Community

Notes and questions about AngioDynamics from other investors

No posts about ANGO yet

Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Where these numbers come from

Parsed from the XBRL in AngioDynamics's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ANGO.

Compare: ANGO vs LMAT · ANGO vs AORT · ANGO vs DCTH · ANGO vs ATRC · ANGO vs ARAY

Revenue growth8.2% · median 13.8%

Gross margin55.7% · median 72.0%

Operating margin-11.2% · median 2.9%

Net margin-10.1% · median 2.5%

Company	Revenue	Growth
ATRC	$589.80M	+13.8%
AORT	$481.88M	+14.0%
ARAY	$394.53M	-12.5%
ANGO	$325.38M	+8.2%
LMAT	$269.36M	+11.8%
DCTH	$109.96M	+38.1%

Company

Next earnings (est.): Jan 5, 2027, before open
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: May 31
Employees: 632
Held by institutions: 91.0%
Auditor: Deloitte & Touche LLP
SEC CIK: 1275187

Advertisement
300 × 250

See a number that looks wrong?